Medicament for treating pulmonary tuberculosis hemoptysis and preparation method thereof

Abstract

The invention discloses a medicament for treating pulmonary tuberculosis hemoptysis and a preparation method thereof and belongs to the field of traditional Chinese medicines. The medicament comprises the following raw materials as active components: shiny chinquefoil herb, lemmaphyllum microphyllum, large angiopteris rhizome, bulbophyllum inconspicuum, abutilon indicum, agaric, piper hancei maxim, bulbophvl-lum peotinatum pinet, aeschynanthus acuminatus wall, running mallow root, didymosperma root, alocasia, rhizoma anemarrhenae, assam crotalaria, gomphrena globosa and Japanese xylosma root. As high-quality traditional Chinese herbal medicines are selected and scientifically combined, the medicament has the efficacies of clearing heat and diminishing inflammation, cooling blood and hemostasis, moistening lung and relieving cough as well as dispelling wind and eliminating dampness, has remarkable treatment effects on treating symptoms such as cough, expectoration, hemoptysis, chest pain as well as different degrees of chest distress and dyspnea caused by phthisis, is convenient to carry, safe and reliable, free of any toxic or side effect and low in cost, can achieve the purposes of treating both symptoms and root causes of disease and is an ideal medicament for treating pulmonary tuberculosis hemoptysis.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a medicine for treating pulmonary tuberculosis hemoptysis and a preparation method thereof. Background technique [0002] Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis, which can invade many organs, with pulmonary tuberculosis infection being the most common. Mycobacterium tuberculosis belongs to Actinomycetes, Mycobacterium genus of Mycobacteriaceae, is a pathogenic acid-resistant bacteria, mainly divided into human, bovine, bird, mouse and other types. Those who are pathogenic to humans are mainly human-type bacteria, and bovine-type bacteria are rarely infected. The resistance of tuberculosis to drugs can be formed by the development of innate drug-resistant bacteria in the flora, or it can quickly develop resistance to the drug due to the single use of an anti-tuberculosis drug in the human body, that is, acquired drug resistan...

AI Technical Summary

Problems solved by technology

[0004] At present, the treatment of pulmonary tuberculosis hemoptysis is generally treated with western medicine or injections. Some western medicines are mostly expensive, and the cost of patients such as going to the hospital for treatment is also high, and the curative effect is slow and the cure rate is low. There are also certain toxic and side effects, so major hospitals are in urgent need of a drug that has a short course of treatment, quick results, and no toxic and side effects